3-METHYL-2- (3- (2-PHENYL-OXAZOL-4-YLMETHOXY)-CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS
摘要
申请公布号
CA2516620(A1)
申请公布日期
2004.09.10
申请号
CA20042516620
申请日期
2004.02.19
申请人
AVENTIS PHARMA DEUTSCHLAND GMBH
发明人
GLOMBIK, HEINER;SCHAEFER, HANS-LUDWIG;KEIL, STEFANIE;FALK, EUGEN;GOERLITZER, JOCHEN;STAPPER, CHRISTIAN;GRETZKE, DIRK;WENDLER, WOLFGANG
